Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Product-news entities : Sanofi save search
Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi
Published: 2023-12-19 (Crawled : 08:00) - biospace.com/
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.91%
H: 0.72%
C: 0.11%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.45%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 13.88%
H: 0.0%
C: -3.58%
pharma natural cell sanofi
FDA Greenlights Provention’s TZIELD as First Drug to Delay Advanced T1D
Published: 2022-11-18 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.56%
H: 0.52%
C: 0.52%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 2.2%
H: 0.0%
C: 0.0%
fda drug
Scientists Report Monkeypox Outbreak was Not Only Preventable, but Expected
Published: 2022-08-19 (Crawled : 18:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.05%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: 0.0%
monkeypox report expected
Sanofi Launches HBCU Diversity Partnership, Stays Strong in Q2 as Dupixent Thrives
Published: 2022-07-28 (Crawled : 18:00) - biospace.com/
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.4%
H: 1.01%
C: 0.17%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: 0.0%
dupixent sanofi
FDA Advisory Committee Calls For Updated COVID-19 Boosters to Quell Omicron
Published: 2022-06-29 (Crawled : 13:20) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
covid-19 fda quell
Bavarian Nordic Takes on Pfizer-BioNTech with COVID-19 Booster Candidate
Published: 2022-06-17 (Crawled : 13:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.76%
H: 5.75%
C: 5.5%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.39%
H: 0.0%
C: 0.0%
covid-19
AVROBIO Reports First Quarter 2021 Financial Results and Provides Business Update
Published: 2021-05-13 (Crawled : 12:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.5%
H: 1.16%
C: 0.98%
AVRO | $1.205 -2.82% -2.9% 39K
|
Health Technology
|
| O: -0.11%
H: 2.73%
C: 0.11%
financial results results
Missing Emails Add Additional Layer to Sanofi's Zantac Recall Drama
Published: 2021-05-12 (Crawled : 05:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.46%
H: 0.95%
C: 0.12%
AUM Biosciences enters in a Strategic Collaboration with Handok and CMG Pharm to develop ‘CHC2014’, New Pan-TRK Inhibitor for Cancer Treatment
Published: 2021-05-11 (Crawled : 14:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.47%
H: 0.7%
C: 0.52%
treatment collaboration cancer
Bigfoot Biomedical® Receives FDA Clearance for Bigfoot Unity™ Diabetes Management System, Featuring First-of-its-Kind Smart Pen Caps for Insulin Pens used to Treat Type 1 and Type 2 Diabetes
Published: 2021-05-10 (Crawled : 18:00) - biospace.com/
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.38%
H: 0.22%
C: -0.72%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.54%
H: 0.17%
C: -0.32%
diabetes fda clearance fda insulin clearance
Checkmate Pharmaceuticals Announces Clinical Supply Agreement with Regeneron to Evaluate Vidutolimod (CMP-001) in Combination with Libtayo® (cemiplimab)
Published: 2021-05-10 (Crawled : 12:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.54%
H: 0.17%
C: -0.32%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: 0.16%
H: 3.21%
C: 0.97%
CMPI | $10.5 0.0%
|
Health Technology
|
| O: 0.42%
H: 4.99%
C: -8.99%
ev
TellBio Unveils Next-Generation Liquid Biopsy Platform Focused on Early Detection and Treatment of Cancer
Published: 2021-05-10 (Crawled : 12:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.54%
H: 0.17%
C: -0.32%
treatment cancer platform
Replimune Provides a Regulatory Update for its Registration- Directed Clinical Trials Evaluating RP1 in Combination with Libtayo® (cemiplimab)
Published: 2021-05-05 (Crawled : 12:15) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.1%
H: 0.59%
C: 0.22%
REPL | $6.47 -7.17% -7.73% 870K
|
Health Technology
|
| O: 2.18%
H: 12.36%
C: 6.47%
clinical trials trial
AVROBIO Provides Regulatory Update on Investigational AVR-RD-01 for Fabry Disease
Published: 2021-05-03 (Crawled : 12:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -4.18%
H: 1.62%
C: 1.41%
AVRO | $1.205 -2.82% -2.9% 39K
|
Health Technology
|
| O: -1.71%
H: 0.17%
C: -17.42%
disease rd-05
Moderna Announces Additional Investments to Increase Global Supply for COVID-19 Vaccine to up to 3 Billion Doses in 2022
Published: 2021-04-29 (Crawled : 08:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.89%
H: 0.09%
C: -0.64%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: 2.6%
H: 1.89%
C: -4.18%
covid vaccine
Sanofi to help manufacture Moderna COVID-19 vaccine, supporting global supply demands
Published: 2021-04-26 (Crawled : 12:15) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.19%
H: 0.12%
C: -0.66%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.46%
H: 0.04%
C: -0.1%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: -1.06%
H: 4.55%
C: 3.39%
covid vaccine covid-19
IDEA Pharma's 10th annual Pharmaceutical Innovation Index: Eli Lilly is the most innovative company for the first time
Published: 2021-04-21 (Crawled : 16:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.07%
H: 0.32%
C: 0.13%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.5%
H: 0.76%
C: -0.32%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.48%
H: 0.59%
C: 0.4%
pharma
Mestag Therapeutics launches with seed financing of $11 million to develop therapeutics targeting activated fibroblast populations across inflammatory disease and cancer
Published: 2021-04-21 (Crawled : 14:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.07%
H: 0.32%
C: 0.13%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.48%
H: 0.59%
C: 0.4%
disease cancer
Evotec Accelerates Access to Biologic Therapeutics with Initiation of Manufacturing Facility in Toulouse
Published: 2021-04-20 (Crawled : 07:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.08%
H: 0.42%
C: 0.42%
Lilly Closes Dermira’s Menlo Park Facility, Cutting 163 Jobs in the Process
Published: 2021-04-13 (Crawled : 16:00) - biospace.com/
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.35%
H: 1.36%
C: 0.75%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.66%
H: 0.86%
C: 0.48%
Gainers vs Losers
| 69% | 31% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
KNW 4 | $0.59 -0.71% 18.64% 27K
|
Manufacturing
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.